Transtimulation Research Inc.
Oklahoma City, OK
- UEI
- DLBFL8DKL6Z3
- CAGE
- 47WV6
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 800 Research Pkwy #337, Oklahoma City, OK 73104, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Eclipse Regenesis, Inc. | Mountain View, CA | — |
| Medical Device R&D | San Francisco, CA | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| (A Development Stage Company) | — | 813990 Other Similar Organizations (except Business, Professional, Labor, and Political Organizations) |
| Dignify Therapeutics, LLC | Durham, NC | — |
| Teliatry Inc. | Richardson, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Transtimulation Research Inc. is a corporate for-profit entity that has been registered to receive federal awards since 2005. The company appears to specialize in developing medical devices and therapies related to neuromodulation and treatment of conditions like bowel dysfunction and gastroparesis.
Through federal grant awards from agencies like the National Institutes of Health (NIH), Transtimulation Research has worked on projects to develop wearable transcutaneous neuromodulation devices. One major award from the NIH's National Institute of Neurological Disorders and Stroke provided over $1.8 million from 2022-2025 to design and evaluate a leg-worn device called "AccelBand" to treat neurogenic bowel dysfunction in spinal cord injury patients by stimulating the ST36 acupuncture point. Another $3.2 million award from the NIH's National Center for Complementary and Integrative Health from 2020-2024 funded development of a wearable electrical acustimulation device for gastroparesis. For the gastroparesis project, Transtimulation Research partnered with the University of Michigan as a sub-awardee to refine the device, create a mobile app, and assist with physiological testing and regulatory approvals. The company's work focuses on leveraging transcutaneous electrical neuromodulation to treat gastrointestinal disorders and restore bodily functions impacted by neurological conditions.
Quick answers
Is Transtimulation Research Inc. registered in SAM.gov?
Yes. Transtimulation Research Inc.'s SAM.gov registration is active through December 5, 2026.
What is Transtimulation Research Inc.'s most recent federal award?
Transtimulation Research Inc.'s most recent federal grant award is Accelband, a leg-worn transcutaneous neuromodulation device for treating neurogenic bowel dysfunction in individuals… (UH3NS125182), from National Institute of Neurological Disorders and Stroke (NIH), on September 15, 2022.
On GovTribe
See Transtimulation Research Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors